Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
256,606,920
-
Total 13F shares
-
244,492,921
-
Share change
-
+2,036,950
-
Total reported value
-
$44,967,052,322
-
Put/Call ratio
-
85%
-
Price per share
-
$183.95
-
Number of holders
-
718
-
Value change
-
+$391,208,371
-
Number of buys
-
362
-
Number of sells
-
270
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q1 2019
As of 31 Mar 2019,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
718 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
244,492,921 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Capital World Investors, WELLINGTON MANAGEMENT GROUP LLP, JENNISON ASSOCIATES LLC, JPMORGAN CHASE & CO, and Clearbridge Investments, LLC.
This page lists
721
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.